newsfilter
← Latest News
GlobeNewswire·

First Wave BioPharma to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

BOCA RATON, Fla., Sept. 05, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), ("First Wave BioPharma" or the "Company"), a clinical-stage biopharmaceutical company specializing in the development of